Healthcare Asia Magazine

26.5% of global population had insulin resistance in 2025.

Asia-Pacific is emerging as the fastest-growing region.

Asia-Pacific drives the fastest growth.

Catheter-based procedures are preferred over traditional surgery.

APAC is expected to see the fastest growth.

It is scheduled to open in the coming months.

This is an improvement from only 6% in 2020.

The industry is expected to become a key international player.

Chronic diseases like COPD, asthma, and cancer are rising.

The report projects 20.9% annual growth as cloud deployments dominate due to lower costs.

The national initiative targets drug affordability and R&D expansion.

Chronic vision conditions are also adding pressure on hospitals and clinics.

Data, methods, software, and code should be shared openly.

It delivers radiation 400 times faster than existing methods.